ArticleMolecular oncology2024

PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.

Josep R Ferreres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.